Consolidation is one of the latest topics lighting the healthcare landscape abuzz, fundamentally altering the landscape of care delivery in recent years in the United States. Consolidation has been particularly notable in the rise of mergers and acquisitions which involve hospitals, insurers, and PBMs alike. As providers and payers adjust to this new reality, PBMs […]
Design Articles
Consolidation in Healthcare: Navigating the New Normal
September 6th, 2024 by Jaylin HortaForces framing the future
August 30th, 2024 by Jaylin HortaThe PBM industry is experiencing a confluence of technological, regulatory, and marketplace changes. For many, this is both welcome and overdue. Organizations now have the opportunity to seize on this moment to spur an evolution in healthcare that will provide a better experience for everyone. To harness this momentum, organizations should: Embrace advanced technology. For […]
Introducing Oasis Connections: A Better Way to Connect and Work Together
August 30th, 2024 by Graciela ColonRethinking Healthcare Leadership Starts with Better Conversations In healthcare—as in business—better outcomes begin with better dialogue. At Abarca Health, we’re more than a pharmacy benefit manager. We’re a company that dares to find a better way. That’s what led us to launch Oasis Connections—a platform for authentic, purpose-driven leadership conversations that spark real change. […]
From preparing prescriptions to driving health outcomes: Evolving the role of pharmacies
August 28th, 2024 by Jaylin HortaIn the minds of many consumers, the role of pharmacists has long been confined to filling prescriptions. Thankfully, that overly simplistic view is changing and pharmacists are finally being recognized for their potential to make a larger impact. During the height of the pandemic, pharmacists made immeasurable contributions by administering COVID vaccines and other immunizations. […]
Ana C. Rivera named 2024 Emerging Leader in Healthcare
August 26th, 2024 by Jaylin HortaWe are thrilled to announce that Ana C. Rivera, VP of Legal & Compliance at Abarca, has been named as a 2024 Emerging Leader in Healthcare by Managed Healthcare Executive® (MHE). Ana has built her career on her passion for affordable and accessible healthcare services. Since her first role supporting Medicaid populations, Ana has […]
The Virtual PBM Revolution: Transforming Healthcare Delivery
August 13th, 2024 by Jaylin HortaIn the rapidly evolving landscape of healthcare, the emergence of Virtual Pharmacy Benefit Managers represents a significant shift towards more dynamic and patient-centric service models. This evolution is reshaping how healthcare delivery and pharmacy services are managed, making them more accessible and efficient. For CEOs and industry leaders, understanding and leveraging the capabilities of Virtual […]
A better way to manage M3P
August 1st, 2024 by Johanses DuartePino.comUnder the CMS Medicare Prescription Payment Plan (M3P), beginning CY 2025, all Medicare Part D plans must offer enrollees the option to spread out their out-of-pocket (OOP) prescription drug costs over the plan year, rather than pay at the point of sale. Among other goals, this initiative aims to: Relieve financial burdens: Under M3P, OOP […]
Enhancing Pharmacy Benefit Management through Interoperability: A Virtual PBM Model
July 25th, 2024 by Johanses DuartePino.comTake a look at our exclusive webinar “Enhancing Pharmacy Benefit Management through Interoperability: A Virtual PBM Model”. Presented by Abarca Health in partnership with Surescripts, this 30-minute webinar will explore and discuss the following topics: An overview of interoperability and the important role it plays in effective Pharmacy Benefit Management. Abarca’s Virtual PBM Model and […]
The Rise of Biosimilars: Navigating the Future of Healthcare
July 5th, 2024 by Johanses DuartePino.comThe healthcare landscape is witnessing a transformative shift with the rise of biosimilars, which are poised to redefine affordability, access, and innovation in medical treatments. As these alternatives to well-known biologic drugs gain traction, they bring both opportunities and challenges that healthcare stakeholders must navigate. What Are Biosimilars? Let’s take a second to catch […]
Election Year 2024: What It Means for Healthcare Policy and Pharmaceutical Pricing
July 1st, 2024 by Jaylin HortaThe 2024 U.S. presidential election is set to have profound implications on healthcare policy and pharmaceutical pricing, issues that are central to the agendas of major political candidates. With healthcare consistently ranking as a top concern for voters, the outcomes of this election could lead to significant shifts in policy, impacting everything from drug prices […]